Siklos Tablet, Film Coated
Product Images NDC 71770-120

Product Visual Gallery

This gallery contains 40 technical images submitted to the FDA as part of the official labeling for Siklos (NDC 71770-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medunik, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Siklos 01)

Chemical structure of hydroxyurea showing its molecular composition with atoms and bonds, including amino, carbonyl, and hydroxyl functional groups.*

FDA Label Image

Figure (Siklos 02)

Siklos 100 mg film-coated tablets, oral, labeled by Medunik. The image shows the Siklos brand name with the strength 100 mg prominently displayed, and a simple black and white schematic of the tablet shape with imprint 'H H.'*

FDA Label Image

Figure (Siklos 03)

Siklos 1,000 mg film-coated tablets by Medunik, shown as four oval tablets arranged horizontally, each tablet imprinted with 'T L T L'. The label highlights the brand name Siklos and the 1,000 mg strength of hydroxyurea in oral tablet form.*

FDA Label Image

Figure (Siklos 04)

An instructional diagram showing a hand under running water from a faucet, illustrating handwashing technique or rinsing.*

FDA Label Image

Figure (Siklos 05)

An instructional illustration showing a gloved hand being put on. The image demonstrates the proper method for donning a glove, typically used to indicate hygiene or safety procedures.*

FDA Label Image

Figure (Siklos 06)

An instructional black-and-white line drawing showing a pair of hands opening a small pill packet by peeling or pulling apart the edges. This illustration likely demonstrates how to open a unit dose medication package.*

FDA Label Image

Figure (Siklos 07)

An instructional line drawing showing hands holding and pinching a film-coated oral tablet labeled Siklos. The simple black-and-white image focuses on the tablet being positioned for administration.*

FDA Label Image

Figure (Siklos 08)

An illustration showing a close-up of fingers holding and breaking a film-coated tablet in half, demonstrating how to split the tablet properly. The image emphasizes the tablet's break line for accurate dosing.*

FDA Label Image

Figure (Siklos 09)

An instructional illustration showing hands holding a small tablet or pill, demonstrating the act of breaking or splitting the tablet, likely to indicate how to properly divide the medication dose.*

FDA Label Image

Figure (Siklos 10)

An instructional illustration showing two hands holding a tablet blister strip, demonstrating how to push a tablet through the blister foil from the backside.*

FDA Label Image

Figure (Siklos 11)

Siklos 100 mg oral film-coated tablet. The white, oblong tablet is embossed with 'H' on one side and 'I' on the other. Labeler: Medunik.*

FDA Label Image

Figure (Siklos 12)

Siklos 100 mg film-coated tablets packaging label. The label shows a white tablet with a round biconvex shape. The product is identified as hydroxyurea, an oral prescription drug, manufactured by Medunik.*

FDA Label Image

Figure (Siklos 13)

An instructional illustration showing two hands breaking a tablet into smaller pieces, demonstrating how to divide a film-coated tablet, possibly for Siklos (hydroxyurea) oral tablets. No text is visible besides the image of the hands and the tablet.*

FDA Label Image

Figure (Siklos 14)

Siklos 100 mg film-coated tablet, oral dosage form, labeled with an 'H' imprint. The tablet is white and oval-shaped, produced by Medunik. This image shows the individual tablet without packaging.*

FDA Label Image

Figure (Siklos 15)

Siklos 100 mg film-coated oral tablet imprinted with 'H H' on one side and scored on the other, manufactured by Medunik. The tablet is oval and white in color.*

FDA Label Image

Figure (Siklos 16)

Siklos 100 mg film-coated tablet imprinted with 'T T L' on one side. It is an oral dosage form of hydroxyurea, a prescription drug labeled by Medunik.*

FDA Label Image

Figure (Siklos 17)

Siklos hydroxyurea 100 mg oral film-coated tablet. The white oblong tablet has scored lines on one side, allowing it to be split. Manufactured by Medunik.*

FDA Label Image

Figure (Siklos 18)

An instructional illustration showing two hands breaking a tablet by applying pressure with both thumbs and forefingers to split the tablet in half.*

FDA Label Image

Figure (Siklos 19)

Siklos 100 mg film coated oral tablets packaging from Medunik. The image shows a white blister pack strip containing round, white tablets with the imprint 'T1' visible on one tablet. The strip is partially cut off and curved, emphasizing the tablet shape and imprint.*

FDA Label Image

Figure (Siklos 20)

Siklos hydroxyurea 100 mg film-coated oral tablets packaging, showing a blister card with ten tablets. The label includes the brand name Siklos, strength 100 mg, dosage form tablet film-coated, and the labeler Medunik. The tablets are arranged in two rows of five.*

FDA Label Image

Figure (Siklos 21)

The image shows a blister pack containing Siklos tablets, film-coated, available in 1000 mg strength. The blister pack holds a total of 3 tablets. The labeler is Medunik, and the medication is hydroxyurea for oral administration.*

FDA Label Image

Figure (Siklos 22)

Siklos hydroxyurea 100 mg film-coated tablet. The white, elongated tablet is scored and embossed with the letters 'TLT' on one side. It is intended for oral administration and labeled by Medunik.*

FDA Label Image

Figure (Siklos 23)

An instructional illustration showing a person holding a small cup and bringing a tablet to the mouth, demonstrating the oral administration of a tablet.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

An illustration showing a close-up of two hands holding each other, suggesting a supportive gesture. The image does not contain any pharmaceutical product or textual information.*

FDA Label Image

Principal Display Panel (1,000 mg Tablet Bottle Label)

An instructional illustration showing a hand lifting the lid of a waste container, with crumpled tissues or paper inside. The image depicts the action of opening the container, possibly for disposal or inspection purposes.*

FDA Label Image

Siklos 26

An instructional illustration showing a person wearing a glove and using a swab or applicator to clean or treat the wrist area. The diagram highlights hand and wrist interaction with the swabbing tool.*

FDA Label Image

Siklos 27

An instructional illustration showing a hand holding a blister pack of tablets over a trash can, indicating disposal of unused medication tablets.*

FDA Label Image

Siklos 28

Illustration showing a hand being rinsed or washed under running water from a faucet. The image appears instructional, focusing on hand hygiene or washing technique, without any text or branding.*

FDA Label Image

Siklos 29

An illustration depicting a single film-coated tablet on a spoon. There is no visible text or markings on the tablet or spoon in the image.*

FDA Label Image

Siklos 30

An illustration showing a single film-coated tablet, identified as Siklos (hydroxyurea), placed on a spoon. The tablet has scored lines on one side, suggesting it can be split. The image visually represents the oral tablet dosage form of this medication.*

FDA Label Image

Siklos 31

An illustration showing a spoon containing two round tablets. The tablets appear film-coated, consistent with an oral dosage form. No specific markings or text are visible on the tablets or spoon.*

FDA Label Image

Siklos 32

An illustration of a spoon containing a granular or powdery substance. The image depicts a close-up view of the spoon's bowl filled with the material, shown in grayscale with shading to indicate texture.*

FDA Label Image

Siklos 33

An illustration showing a single film-coated tablet placed on a spoon, representing the oral dosage form of Siklos hydroxyurea tablets. The image emphasizes the tablet's size and administration method.*

FDA Label Image

Siklos 34

An illustration of a spoon containing a white granular or powdered substance. The image shows the spoon from a top-side angle, focusing on its contents.*

FDA Label Image

Siklos 35

An illustration showing an adult administering oral medication to a child using a small spoon, demonstrating the technique for giving liquid medicine.*

FDA Label Image

Siklos 36

An instructional illustration showing a person drinking water from a glass, likely demonstrating how to take oral medication such as the Siklos film-coated tablet.*

FDA Label Image

Siklos 37

Packaging label for Siklos hydroxyurea tablets showing two strengths: 100 mg and 1,000 mg. The 100 mg film-coated tablets are displayed with a gold-themed bottle and box. The 1,000 mg film-coated tablets appear with a red-themed bottle and box. The label illustrates tablet breaking guidance and dosage handling instructions for both strengths.*

FDA Label Image

Siklos 38

Packaging label for Siklos 1,000 mg (hydroxyurea) tablets, film coated, oral use. The label shows the drug name, strength, and dosage form prominently with warnings about myelosuppression and malignancies. Instructions to handle the tablets with disposable gloves and to store between 20°C to 25°C are included. The package contains 30 tablets and is labeled by Medunik, with manufacturer and distributor information noted. The label includes a bar code and directions for pharmacists to provide a Medication Guide.*

FDA Label Image

Siklos 39

Siklos 100 mg film-coated tablets label showing hydroxyurea as the active ingredient. The label states 100 mg per tablet, package contains 60 tablets, and the product is for oral use. It includes storage instructions, handling precautions, and distributor information from Medunik USA, Inc. A barcode, lot number, and expiration date fields are also visible.*

FDA Label Image

Siklos 40

Packaging label for Siklos 100 mg (hydroxyurea) oral film-coated tablets by Medunik. The label indicates 100 mg per tablet strength, 60 tablets per container, storage instructions at 20°C to 25°C, and warnings including myelosuppression and malignancies. The label includes handling precautions and pharmacist instructions for enclosed Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.